ResearchNet - RechercheNet

Table of Contents

• Description
• Objectives
• Eligibility
• Guidelines
• Performance Measurement
• Review Process and Evaluation
• How to Apply
• Contact Information
• Additional Information

Description

Priority Announcements on New Investigator Salary Award competitions offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas or mandates. Applications are submitted through the "201512MSH" competition of the New Investigator Salary Award: 2015-2016 funding opportunity.

The New Investigator Salary Award program is designed to provide outstanding New Investigators the opportunity to develop and demonstrate their independence in initiating and conducting health research through provision of a contribution to their salary. A New Investigator is defined as a researcher who has held a full time research appointment for a period of 0 to 60 months as of the December competition deadline.

Funds Available

CIHR's and partner contribution to the amount available for this initiative is subject to availability of funds. Should CIHR or partner funding levels not be available or are decreased for some unforeseen circumstances, CIHR and partner reserve the right to defer or suspend payments to awards received as a result of this funding opportunity.

Funds Available for Research in All Areas

Funds are available for applications in all areas of research that address any important health problem or issue through the "201512MSH" competition of the New Investigator Salary Award: 2015-2016 funding opportunity.

Funds Available for Research in Specific Areas

In this competition, funds are available to encourage and support applications in specific areas that are aligned with CIHR's research priority areas and mandates. Information on the research areas to be funded as well as the maximum amounts per award that can be requested is found in the "Objectives" section.

• Drug Safety and Effectiveness
• Infection and Immunity
• Inflammatory Bowel Disease (Updated: 2015-09-11)
• Ontario HIV Treatment Network
• Research in First Nations, Inuit and/or Métis Health

Objectives

The specific objective of the New Investigator Salary Award: Priority Announcement (Specific Research Areas) is to offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas and mandates.

Drug Safety and Effectiveness (NDR)

Summary

• The Drug Safety and Effectiveness Network (DSEN) will provide funding for clinical research that is relevant to its mandate.
• DSEN addresses gaps in information on the safety and effectiveness of prescription drugs used by Canadians in the real-world.
• Research involving Over-the-counter Drugs, Medical Devices and Natural Health Products (including vitamins and minerals, herbal remedies, homeopathic medicines, traditional medicines such as traditional Chinese medicines, probiotics, and other products such as amino acids and essential fatty acids) will not be considered relevant to this funding opportunity.
• More information on the research priorities of DSEN can be found on their website.

Funds Available

• The total amount available for this funding opportunity is $600,000.
• The maximum amount awarded for a single award is $60,000 per annum for up to five (5) years.

Specific Requirements

• This Priority Announcement will require the completion of a Relevance Form.
• The award must be held in Canada.
• The successful applicants will become a DSEN collaborating researcher. Therefore, he/she may be required to be actively participating in DSEN activities supporting the network such as advisory committees and/or knowledge translation event(s) organized by the DSEN Coordinating Office.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Infection and Immunity (INI)

Summary

• The Institute of Infection and Immunity (III) has the mandate to support research to enhance immune-mediated health and to reduce the burden of infectious disease, immune-mediated disease and allergy through prevention strategies, screening, diagnosis, treatment, support systems and palliation. The III mandate transcends disciplines and encompasses all four CIHR health research themes.
• The CIHR Institute of Infection and Immunity will provide funding for applications that are determined to be relevant to the following strategic research priorities:
  • Antimicrobial resistance;
  • Existing and emerging microbial threats;
  • Vaccines development;
  • Improved diagnostics directly related to infection and immunity;
  • Inflammation;
  • Microbiome;
  • Transplantation;
  • Human immunology and immunotherapy.
• More information on the research priorities of CIHR-III can be found on their website.

Funds Available

• The total amount available for this funding opportunity is $600,000, enough to fund two (2) awards. This amount may increase if additional funding partners or internal collaborators decide to participate.
• The maximum amount awarded for a single award is $60,000 per annum for up to five (5) years.

Specific Requirements

• This Priority Announcement will require the completion of a Relevance Form.
• The award must be held in Canada.
• Trainees must propose a research training program in Canada to be eligible for this award.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Inflammatory Bowel Disease (XGP) (Updated: 2015-09-11)

Summary

• The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) in partnership with Crohn’s and Colitis Canada (CCC) and the Canadian Association of Gastroenterology (CAG) will provide funding for applications that are determined to be relevant to the research priority areas as described below:
  • Biomedical or clinical research related to Inflammatory Bowel Disease that will contribute to building increased Canadian research capacity in the field.
• More information on the research priorities of CIHR-INMD, CCC, and CAG can be found on their websites.

Funds Available

• The total amount available for this funding opportunity is $300,000 enough to fund one (1) award. This amount may increase if additional funding partners or internal collaborators decide to participate.
• The maximum amount awarded for a single award is $60,000 per annum for up to five (5) years.
• This award is non-renewable.

Specific Requirements

• This Priority Announcement will require the completion of a Relevance Form.
• Applicants must ensure that their relevance form addresses the following points:
  • A short statement explaining how the proposed research will strengthen Canadian IBD research;
• The Nominated Principal Applicant must be a CAG Regular Member in good standing at the time of application or have applied to become a CAG Regular member and a CCC IBD Research Institute member.
• In order to demonstrate value to donors and volunteers, the CCC requires that successful applicants submit a lay annual report to the CCC (with a copy to CAG) every year and a final report within two months of the completion of the research project, and provide CCC with copies of any research publications, presentations or other grants that have resulted from this award. Successful applicants also agree to speak to a lay audience or to write an article on their research upon CCC’s request.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Ontario HIV Treatment Network (NEB/NEP)

Summary

• The Ontario HIV Treatment Network (OHTN) will provide funding for applications that fulfill the objectives of the OHTN’s Research Funding Policy: Funding Research with Real-Life Impact.
• The goal of this priority announcement is to enable the OHTN to support New Investigators conducting solution-focused, scientifically rigorous, community-engaged, multi-disciplinary HIV research that is highly relevant to one or more of the populations in Ontario most affected by HIV:
  • people living with HIV;
  • gay men and other men who have sex with men;
  • African, Caribbean and Black men and women;
  • Aboriginal men and women;
  • men and women who use drugs; and
  • women who have unprotected sex or share drug equipment with people from these populations.
• This priority announcement will provide funding for applications that demonstrate relevance to the Policy, and that have the potential to have an impact on people living with and affected by HIV in Ontario within 2-5 years. We are particularly interested in funding people who are using a program science / implementation science framework and approach, developing and testing interventions, “solving” problems, and doing work to influence new / adapt existing programs, services and policies for persons affected by HIV in Ontario.
• Investigators funded through this program are expected to work collaboratively with other OHTN stakeholders (people living with and affected by HIV, front-line community-based agencies, health care providers, scientists, health planners and government decision-makers) where appropriate, to enhance Ontario’s research leadership, health systems and health services.
• Applications to the OHTN priority announcement are sought in two distinct funding pools: Biomedical/Clinical Research and Health Services/Population Health Research. Applicants must select the most relevant funding pool in the drop-down menu of the priority announcement.
• More information on the Ontario HIV Treatment Network can be found on their web site.

Funds Available

• The total amount available for this funding opportunity is $600,000.
• The maximum amount awarded for a single award is $60,000 per annum for up to five (5) years.
• Of the total funds available,
  • $300,000 is available to fund applications relevant to the Biomedical/Clinical Research funding pool;
  • $300,000 is available to fund applications relevant to the Health Services/Population Health Research funding pool.

Specific Requirements

• This Priority Announcement will require the completion of a Relevance Form.
• Applicants must select the most relevant funding pool in the drop-down menu of the priority announcement.
• Only applications from Ontario-based investigators will be eligible for OHTN funding.
• Full-time employees of the OHTN are not eligible for funding, however new investigators supported through the time-limited (1-2 year) OHTN Researcher-in-Residence development program may apply to this Priority Announcement.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Research in First Nations, Inuit and/or Métis Health (NFI)

Summary

• The CIHR Institute of Aboriginal Peoples' Health (IAPH) fosters the advancement of a national health research agenda to improve and promote the health of First Nations, Inuit and Métis Peoples in Canada, through research, knowledge translation and capacity building. The Institute's pursuit of research excellence is enhanced by respect for community research priorities and Indigenous knowledge, values and cultures.
• More information on the research priorities of CIHR-IAPH can be found on their website.

Funds Available

• The total amount available for this funding opportunity is $600,000, enough to fund two (2) awards. This amount may increase if additional funding partners or internal collaborators decide to participate.
• The maximum amount awarded for a single award is $60,000 per annum for up to five (5) years.

Specific Requirements

• This Priority Announcement will require the completion of a Relevance Form.
• Within the Relevance Form the applicant must demonstrate:
  • a close working relationship with a First Nations, Métis or Inuit organisation or community; and,
  • how their lived “Indigenous Lived Experience” will enhance their approach to research.*
• Successful applicants may be required to budget funds to attend and actively participate in IAPH activities, such as a yearly research meeting to advance Indigenous health research.
• Awardees must submit a final report within six (6) months of the end of the award.

* Please note that Indigenous identity (i.e., being First Nations, Inuit or Métis) is not a sufficient response to the above. “Indigenous Lived Experience” could be demonstrated by individuals that have close relationships and experience with Indigenous Peoples such as living an extended period of time (e.g., 5 years or more) on a reserve or Northern Inuit community, or through “Indigenous Lived Experience” with people other than First Nations, Inuit or Métis – e.g., Pacific Islanders, or South American Indigenous Peoples.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Eligibility

For Eligibility, please refer to the New Investigator Salary Award: 2015-2016 funding opportunity.

Guidelines

For Guidelines, please refer to the New Investigator Salary Award: 2015-2016 funding opportunity.

Performance Measurement

For Performance Measurement, please refer to the New Investigator Salary Award: 2015-2016 funding opportunity.

Review Process and Evaluation

Relevance Review

CIHR and partner organizations will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described in the "Objectives" section.

Prior to peer review, CIHR and partner organizations will have access to project titles and project summaries and/or relevance forms.

Applications that are not deemed to be relevant will be withdrawn from the competition.

Peer Review

A CIHR review committee will evaluate the full applications. The committee may be drawn from one of CIHR's pre-existing committees or may be created specifically for this funding opportunity. Committee members are selected based on suggestions from many sources including the institute(s) / branch(es) and partner(s), following the Conflict of Interest and Confidentiality Policy of the Federal Research Funding Organizations. For information on CIHR's peer review process in general, see the Understand Peer Review section of CIHR's website.

Evaluation Criteria

New Investigator Salary Awards are reviewed in accordance with the CIHR Peer Review Manual for Salary Award Applications.

The following standard criteria for evaluating applications will apply:

• Applicant Track Record
• Research Plan
• Environment and Support

Note that reviewers will evaluate if the candidate has shown promise to become an independent researcher.

If the applicant does not hold current operating funds, internal and external reviews as well as the summary of discussion from the applicant's submission for a CIHR operating grant (or equivalent), submitted as part of the New Investigator application package, will be used to assist in the evaluation of the New Investigator Salary Award application.

Funding Decision

Upon completion of peer review, we will generate a ranking list, ratings and recommendations. The list will be used for funding decision-making purposes and will remain anonymous unless applicants have provided written consent to share nominative information.

Applications will be funded from the top down in order of ranking as far as budgets will allow.

Applications that receive a rating below 3.5 will not be funded.

How to Apply

Important: Please read all instructions to familiarize yourself with the application process before applying. For new applicants or for those wanting a reminder of the main application procedures, an overview of CIHR's application processes can be found under "Apply for Funding". Note that these are general instructions only as the specific application instructions for this funding opportunity are located below.

• The application process for this funding opportunity is comprised of one (1) phase: Application.
• Applications are submitted through the "201512MSH" competition of the New Investigator Salary Award: 2015-2016 funding opportunity.
• To complete your Application, follow the specific application guidelines and instructions which are fully described in the New Investigator Salary Award: 2015-2016 "How to Apply" section.
• Reminder to applicants: Please ensure that your application is complete (includes all required signatures) and is submitted on time to CIHR.

Specific Requirements

• To apply for funding through these priority announcements, select the priority announcement title and relevant research area(s) addressed by your research proposal in the "Identify Priority Announcements and Relevant Research Area" section of your ResearchNet application.
• You may request that your application be considered for up to three (3) priority announcement research areas per application, in each New Investigator competition.

Contact Information

For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

Priority Announcement Program Delivery Team
Canadian Institutes of Health Research
Telephone: 613-957-8641
Fax: 613-954-1800
Email: PA-AP@cihr-irsc.gc.ca

If you are experiencing technical difficulties with your ResearchNet account or the e-Submission process contact:

CIHR ResearchNet Support
Canadian Institutes of Health Research
Telephone: 613-941-9080
Email: support@researchnet-recherchenet.ca

Additional Information

Drug Safety and Effectiveness (NDR)

• For questions about this initiative and research objectives contact:

  Christian Brochu
  Project Manager
  CIHR – Drug Safety and Effectiveness Network (DSEN)
  Telephone: 613-948-2786
  Fax: 613-954-1800
  Email: christian.brochu@cihr-irsc.gc.ca

Infection and Immunity (INI)

• For questions about this initiative and research objectives contact:

  Serge Desnoyers
  Assistant Director
  CIHR – Institute of [Infection and Immunity (III)
  Telephone: 418-525-4444 x46251
  Fax: 418-577-4689
  Email: serge.desnoyers@crchul.ulaval.ca

Inflammatory Bowel Disease (XGP)

• For questions about this initiative and research objectives contact: (Updated: 2015-09-11)

Paul Sinclair
Executive Director
Canadian Association of Gastroenterology (CAG)
224-1540 Cornwall Road
Oakville, ON L6J 7W5
Telephone: 905-829-2504
Toll-free: 1-888-780-0007
Fax: 905-829-0242
Email: cagoffice@cag-acg.org

Aida Fernandes
Chief Science & Education Officer
Crohn’s and Colitis Canada
60 St. Clair Avenue East, Suite 600
Toronto, ON M4T 1N5
Telephone: 416-920-5035 ext. 214
Toll-free: 1-800-387-1479
Fax: 416-929-0364
Email: afernandes@crohnsandcolitis.ca

Kimberly Banks Hart
Assistant Director
CIHR – Institute of Nutrition, Metabolism and Diabetes (INMD)
Telephone: 613 941-6465
Fax: 613-954-1800
Email: kimberly.bankshart@cihr-irsc.gc.ca

Ontario HIV Treatment Network (NEB/NEP)

• For questions about this initiative and research objectives contact:

  Jane Hutchison
  Associate
  CIHR – HIV/AIDS Research Initiative
  Telephone: 613-948-9396
  Fax: 613-954-1800
  Email: Jane.Hutchison@cihr-irsc.gc.ca

Research in First Nations, Inuit and/or Métis Health (NFI)

• For questions about this initiative and research objectives contact:

  Jeff LaPlante
  Project Officer
  CIHR – Institute of Aboriginal Peoples’ Health (IAPH)
  Telephone: 778-782-9628
  Email: jlaplant@sfu.ca